Response to Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies Kremer, J., Dougados, M., Genovese, M. C., Emery, P., Yang, L., de Bono, S., Holzkaemper, T., Iikuni, N., Schlichting, D. E., Smolen, J. S. WILEY-BLACKWELL. 2015

View details for Web of Science ID 000370860202314